Costs to Health Services and the Patient of Treating Tuberculosis: A Systematic Literature Review
2015
Background
Novel tuberculosis (TB) drugs and the need to treat drug-resistant tuberculosis (DR-TB) are likely to bring about substantial transformations in TB treatment in coming years. An evidence base for cost and cost-effectiveness analyses of these developments is needed.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
110
References
77
Citations
NaN
KQI